Dr. Levy joined Frazier Healthcare Ventures in mid-2007 as a Venture Partner to the medical device team. Dr. Levy brings to Frazier Healthcare more than 30 years of senior operational experience in the medical device industry. Most recently, he was the President and CEO of Northstar Neuroscience, a company developing innovative therapies for neurological diseases and disorders. Currently he serves on the board of Frazier portfolio company BaroSense, Inc., which is developing a minimally invasive implant to treat obesity, and the boards of Calypso Medial, Intuitive Surgical, Inc. and Proteus.

Dr. Levy previously served as President and CEO of Heartstream, a company that developed, manufactured, and marketed an innovative automatic external defibrillator (AED) that revolutionized the treatment of sudden cardiac arrest. He successfully guided the company through product development, several rounds of venture financing, FDA clearance and product launch, manufacturing scale-up, an IPO, worldwide sales and distribution, and ultimately orchestrated the sale of the company to Hewlett-Packard. Prior to joining Heartstream, he was President of Heart Technology, a company that developed, manufactured, and marketed devices for removing plaque from coronary arteries. Dr. Levy effectively led Heart Technology through key business and product development milestones including FDA clearance, manufacturing scale-up, an IPO, and worldwide sales and distribution. The company was sold to Boston Scientific in 1995. Before joining Heart Technology, Dr. Levy was Vice President of Research and New Business Development and a member of the Board of the Ethicon division of Johnson & Johnson. At Ethicon, he was responsible for the acquisition and/or development of a large number of medical products, including synthetic absorbable sutures, coronary stents, surgical staplers and other mechanical wound closure products, growth factors for accelerated wound healing, and devices for minimally invasive surgery.

Dr. Levy is a member of the Board of Trustees of Seattle Biomedical Research Institute, a not-for-profit institute conducting research on infectious diseases such as AIDS, malaria and pneumonia. He received his B.S. in chemistry from City University of New York and his Ph.D. in organic chemistry from Purdue University.

Feel free to contact him at alan.levy@frazierhealthcare.com